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Abstract
Fatty acid-free albumin has been the standard carrier for intravenous infusion of fatty acids to study in vivo lipid
metabolism. However, subjects can have adverse reactions to infusion of albumin. We sought an alternative to albumin
as a carrier for intravenous infusion of fatty acids, using the pig as a model. Cyclodextrins are naturally occurring
water-soluble molecules that can serve as carriers for lipid-soluble compounds. 13C-palmitate was complexed to either
Ž20% methyl--cyclodextrin, 20% 2-hydroxypropyl--cyclodextrin, or 5% porcine albumin isotopic purity of infusates:
. 13 1399.220.06% . C-palmitatealbumin was infused under fed conditions and C-palmitatemethyl--cyclodextrin was
infused under fasted and fed conditions in 50-kg pigs. Palmitate remained in solution at 4C in methyl--cyclodextrin,
but precipitated at 2530C in 2-hydroxypropyl--cyclodextrin. Pigs infused with 13C-palmitatemethyl--cyclodextrin
maintained normal body temperature and appetite; those infused with 13C-palmitatealbumin became anorexic and
exhibited other negative side effects to albumin. Palmitate oxidation rates under fed conditions were similar using either
13C-palmitatemethyl--cyclodextrin or 13C-palmitatealbumin complexes. Fasting increased 13C-palmitatemethyl--
cyclodextrin oxidation by approximately eight-fold. These data suggest that methyl--cyclodextrin may be a suitable
substitute for albumin in fatty acid metabolism studies in swine.  2001 Published by Elsevier Science Inc.
Keywords: Albumin; Fasted; Fatty acid oxidation; Fed; Methyl--cyclodextrin; Palmitate; Swine; Tracer methodology
1. Introduction
Fatty acid-free serum albumin has been the
tracer carrier of choice for lipid metabolism stud-
 Mention of trade name, proprietary product or vendor
does not constitute a guarantee or warranty of the product by
the US Department of Agriculture or imply its approval to the
exclusion of other products or vendors that also may be
suitable.
 Corresponding author. Current address: FDA
ŽCDRHOST Laboratory of Large Animal Research HFV-
.500 , 8401 Muirkirk Rd., Laurel, MD 20708, USA. Fax: 1-
301-827-8108.
Ž .E-mail address: dwc@cdrh.fda.gov D. Wray-Cahen .
Ž .ies Wolfe et al., 1980; Wolfe, 1992 and human
albumin has been used in numerous stable iso-
topic studies, in both humans and dogs, with no
Ž .apparent ill effects Wolfe, 1992 . However, not
all subjects tolerate high infusion rates of al-
bumin, limiting the amount of stable isotopic
tracer that can be infused. Although negative
reactions to 5% albumin infusions are relatively
Ž .rare McClelland, 1990 , albumin infusion can
cause pyrogenic and anaphylactic reactions in hu-
Žmans Stafford et al., 1988; Gales and Erstad,
.1993; Pool and McLeod, 1995 and in animals
Ž .Ring et al., 1977 . The safety of the common
practice of infusion of human albumin in the
1095-643301$ - see front matter  2001 Published by Elsevier Science Inc.
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Table 1
Ž . Ž .  Ž .  Ž . Ž .Feed intake FI , palmitate PA rate of appearance R PA , CO production rate R CO and palmitate oxidation for individual animals when albumin ALB was used as aa 2 a 2
13carrier for C-palmitate tracer in growing pigs
a RŽ .Pig Body ALB Adverse PA oxidation PAFI kg a
1 1 1Žmol minŽ . Ž . Ž .wt. kg conc. response s to mol min kg uptakeBefore start After start 1 .kgŽ .% of ALB-PA oxidizedof ALB-PA of ALB-PA
Ž .infusion %b c PA COinfusion infusion 2
eA 55.1 7 1.44 0 Vomited after 3.63 768 0.646 17.8
60 and 105 min,
shaking
eB 53.7 5 1.38 0 Vomited after 1.53 1100 0.078 5.1
50 and 135 min,
shaking
eC 58.4 5 1.44 0 Vomited after 1.86 630 0.111 6.0
50 min
eD 59.4 5 1.44 0 None observed 2.17 824 0.195 9.0
fE 63.3 5 1.50 0 Listless, shaking 5.69 841 0.554 9.7
f h d dF 54.9 5 1.44 0.72 Listless, full FI 3.87 ND 0.327 8.4
G 49.6 5g 1.32 0.22 Listless, 4.41 744 0.136 3.1
reduced FI
a One additional pig was infused, but is not shown because its catheters shut down when ALB-PA was infused. This pig also stopped eating and had labored breathing.
b Feed consumed over 6 h prior to initiation of ALB-PA infusion, including FI during bicarbonate infusion. Animals offered 4.2 g h1 kg1.
c Feed consumed over 3 h during the ALB-PA infusion. Animals offered 4.2 g h1 kg1.
d Ž . Ž .Estimated using R CO values from other pigs not used in comparison with methyl--cyclodextrin infusion .a 2
e Ž .Essentially fatty acid-free porcine albumin Sigma, A9422 .
f Ž .Essentially fatty acid-free bovine albumin Sigma, A9205 .
g Ž .Essentially fatty acid-free, essentially globulin-free porcine albumin Sigma, A1173 .
h Ž .ND, not determined bicarbonate infusion line disconnected .
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management of certain illnesses in patients has
recently been an issue of discussion and contro-
Ž .versy McClelland, 1998; Offringa, 1998 . It has
been suggested that infusion of albumin may in-
crease the relative risk of death in some circum-
Ž .stances Cochrane Injuries Group, 1998 . In addi-
tion to the possible risk of its use, human albumin
for infusion can be very expensive and its avail-
ability has been limited. Infusion-quality albumin
has not been readily available commercially for
all species of animal models. Some researchers
Žhave used autologous serum as a carrier Dunshea
.et al., 1992 , but this may not always be feasible,
especially if it is necessary to infuse a large
amount of tracer. Using a non-blood-derived car-
rier for infusion of fatty acids in metabolism
studies may reduce the potential risk of albumin
infusion and reduce the cost of the infusate as
well.
In a series of preliminary studies, we infused
several pigs with a variety of fatty acid-free al-
bumin preparations from both porcine and bovine
Ž .sources see Table 1 . However, the palmitateal-
bumin mixtures that we infused into growing pigs
consistently caused adverse reactions, including
anorexia, vomiting, and elevated body tempera-
ture. In order to avoid these negative reactions,
we sought a non-blood-derived alternative to
serum albumin for use as a fatty acid-tracer car-
rier in fatty acid oxidation studies.
-Cyclodextrins can prevent the precipitation
of non-polar substances in aqueous solutions
Ž .McDonald and Muzumdar, 1998 . Data from in
vitro studies suggested that -cyclodextrins may
have potential as fatty acid-tracer carriers in fatty
Ž .acid oxidation studies Kato et al., 1993, 1994 ,
and unsubstituted or natural -cyclodextrin has
been shown to behave similarly to defatted serum
Žalbumin in in vitro preparations Ramadoss et al.,
.1976 . Intravenously infused substituted -cyclo-
dextrins have also been used as carriers for a
wide variety of non-water-soluble substances in
Žhumans Irie et al., 1992; Vandewoude et al.,
. Ž . Ž1997 , rabbits Irie et al., 1992 , rats Packard and
. Ž .Teather, 1997 and dogs Loscher et al., 1995 .
The parent compound, -cyclodextrin, is a cyclic
oligosaccharide consisting of seven glucopyranose
units with a hydrophobic interior. Water solubility
Žof natural -cyclodextrin is poor 1.8 g per 100
. Žml , but chemical substitutions e.g. methyl and
.hydroxypropyl groups can increase the solubility
Ž .many fold 50 g per 100 ml . The objective of
the present study was to determine the feasibility
of using -cyclodextrins as non-blood-derived car-
riers for palmitate in fatty acid oxidation studies
in growing pigs.
2. Materials and methods
2.1. Animals
We used unanesthetized crossbred female pigs
Ž .Sus scrofa domestica 52 3 kg, from the
Ž .Beltsville Agricultural Research Center BARC
swine herd to demonstrate the feasibility of using
methyl--cyclodextrin as a substitute for albumin
as a carrier for 13C-palmitate in in vivo infusion
studies. All animal care and use procedures were
approved by the BARC Institute Animal Care
and Use Committee. Pigs were restrictively fed a
cornsoybean meal based diet at 80% estimated
ad libitum intake based on individual body weight
Ž 1 .diet: 18% crude protein, 3.14 Mcal kg , and
were housed in metabolism crates for at least 1
week before study. Before being placed in crates,
pigs were trained to breathe into a breath collec-
tion mask.
Catheters were non-surgically placed in the
Ž .jugular veins via both medial auricular veins
 1under general anesthesia 2 mg kg each of
Žxylazine and Telazol Fort Dodge Laboratories
.Inc., Fort Dodge, IA to allow for simultaneous
Ž .sampling and infusion Wray-Cahen et al., 1993 .
Measurements were taken at least 4 days after
catheterization. Kinetic measurements were car-
ried out under steady-state fed or fasted condi-
tions.
In preliminary studies, eight pigs were infused
with 13C-palmitatealbumin complexes. The ad-
verse responses to the albumin infusion are shown
in Table 1. The initiation of the 13C-palmitate
albumin infusion appeared to cause three pigs to
vomit within 1 h and to cause the catheters of one
pig to lose patency. Only two pigs infused with
the 13C-palmitatealbumin complex continued to
Žconsume feed throughout the infusion period one
.at a reduced intake . Two other pigs stopped
Žeating, but did not vomit. Three pigs 57.44.1
.kg were used as a comparison for the four pigs
Ž . 1350.5 0.9 kg infused with the C-pal-
mitatemethyl--cyclodextrin complex. Each pig
given the 13C-palmitatemethyl--cyclodextrin
complex was infused under both fed and fasted
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conditions, on two separate, non-consecutive days.
The pigs receiving the 13 C-palmitate 
albumin complex were infused only under fed
conditions. Under fed conditions, pigs received
one-tenth of their daily ration, hourly, beginning
2 h before basal samples were collected and cont-
inuing throughout the collection period, so that
the entire ration was consumed over a 9-h period.
Under fasted conditions, collections began fol-
lowing an 18-h fast. Feed refusals were recorded.
Rectal body temperatures were recorded during
two of the infusions for each infusate.
2.2. Infusate preparation
 13  Ž .1- C -Palmitate potassium salt; 99AP was
Ž .obtained from Mass Trace Inc. Woburn, MA . In
 13 the present investigation, 1- C -palmitate was
Ž .bound to one of three potential carriers: i essen-
Žtially fatty acid-free albumin Sigma Chemical
Co., St. Louis, MO: bovine, A9205; porcine, A-
9422; and porcine essentially globulin-free, A1173;
. Ž .see Table 1 for details ; ii methyl--cyclodextrin
ŽAldrich Chemical Co. Inc., Milwaukee, WI;
. Ž .33,261-5 ; and iii 2-hydroxypropyl--cyclodextrin
Ž . Aldrich Chemical Co. Inc.; 33,260-7 . The 1-
13  Ž .C -palmitate potassium salt was dissolved in
pyrogen-free deionized H O and then added to a2
Ž5% wv albumin solution 5 g albumin per 100 ml
.sterile physiological saline as described by Wolfe
Ž .  13 1992 using 3 g of 1- C -palmitate per 100 g
essentially fatty acid-free albumin. The solution
was prepared at 60C, filtered through a 0.2-m
sterile filter into a sterile bottle and stored at
room temperature until used the following day.
 13  Ž .The 1- C -palmitate potassium salt cyclo-
dextrin complexes were prepared as follows.
Methyl--cyclodextrin or 2-hydroxypropyl--
cyclodextrin was dissolved in sterile phosphate-
Žbuffered saline PBS, GIBCO-BRL, Life Tech-
.nologies, Grand Island, NY; 14190-151 at
5060C at 20 g of -cyclodextrin per 100 ml PBS
Ž .  13  Ž .20% wv . The 1- C -palmitate potassium salt
was directly dissolved in one of the 20% cyclodex-
trin solutions at 3 g of palmitate per 100 g -
cyclodextrin. The mixtures were prepared at
5060C and filtered through a 0.2-m sterile
filter into a sterile bottle and stored at 4C until
 13 infused. The 1- C -palmitatemethyl--cyclo-
dextrin mixture was reheated to approximately
30C, if necessary, to clarify the solution before
infusion. The hydroxypropyl--cyclodextrin mix-
ture was not used in infusion studies for reasons
described below. The final infusate enrichments
Ž .99.22 0.06% and palmitate concentrations
were determined by gas chromatography-mass
Žspectrometry Metabolic Solutions Inc.; Merri-
.mack, NH . The final palmitate concentration af-
ter filtering of both the 5% albumin and the
methyl--cyclodextrin infusate preparations was
75.21.8% of the calculated values. During the
preparation of the 7% albumin infusate, a greater
proportion of the palmitate was lost, and the final
palmitate concentration was 66.7% of the calcu-
lated amount. Values used in the palmitate oxida-
tion calculations were those determined by mass
spectrometry analysis.
2.3. Stability of palmitate-cyclodextrin complexes
As with the palmitatealbumin mixture, the
palmitatemethyl--cyclodextrin mixture re-
mained in solution when it was cooled to room
temperature. Unlike the palmitate-albumin mix-
ture, it also remained in solution when stored at
4C for more than 2 weeks. When the
palmitatemethyl--cyclodextrin mixture was
stored for periods of over 1 month, the palmitate
began to precipitate, but it quickly resolubilized
when heated to approximately 30C. Upon
cooling, the palmitatemethyl--cyclodextrin re-
mained in solution. The palmitate solubilized in
2-hydroxypropyl--cyclodextrin precipitated out of
solution when cooled to 2530C. It could be
resolubilized with heating, but would only remain
in solution if kept warm. Therefore, we de-
termined that the 2-hydroxypropyl--cyclodextrin
complex was not suitable for the in vivo infusion
studies.
2.4. Infusion protocol
ŽA 90-min primed-continuous 0.6 or 1.2 mmol
1 1 .kg h , fed or fasted conditions, respectively
13 Ž .infusion of NaH CO Mass Trace Inc. was3
Žused to prime the CO bicarbonate pool as de-2
.scribed by Wolfe, 1992 and to determine basal
CO production. Immediately following the2
13  13 NaH CO infusion, 1- C -palmitate solutions3
Ž 13were infused at a constant rate 0.068 mol C-
1 1.  13 palmitate min kg for 4 h. The 1- C -
palmitate-albumin mixture was administered at a
rate of 0.89 ml h1 kg1 to achieve the target
 13 tracer infusion rate. Because the 1- C -palmi-
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tate-methyl--cyclodextrin mixture was four-fold
more concentrated than the albumin complex, the
solution was infused at one-fourth the volume
h1 kg1. Breath and blood samples were col-
lected during a basal, pre-infusion period, and
when isotopic enrichment plateau was achieved
Ž6090 min for bicarbonate infusion and 120180
.min for palmitate infusion . Additional samples
were collected to ensure that a plateau had been
Žachieved bicarbonate: t 30, 45, 60, 70, 80 and 90
min; palmitate: t 30, 60, 90, 120, 135, 150, 165 and
.180 min , but these were not included in the
calculations. One animal was infused with the
palmitatemethyl--cyclodextrin mixture for 360
min with samples taken every 30 min for further
verification that the plateau was achieved before
Žthe 120180-min window. Samples breath andor
.heparinized blood were injected into evacuated
vials for measurement of 13CO enrichments.2
Blood samples were collected into heparinized
syringes and plasma was harvested after centrifu-
gation for measurement of plasma enrichments of
 13 1- C -palmitate. Breath and plasma enrichments
Žwere determined by mass spectrometry Meta-
.bolic Solutions Inc., Merrimack, NH .
2.5. Mass spectrometry analysis
 13 1- C -Palmitate enrichment in plasma and in-
fusate was determined by gas chromatography-
Ž .mass spectrometry GCMS on a Hewlett Packard
Ž .5989A system Palo Alto, CA using a Restek
Rtx-1 capillary column. Extracted fatty acids were
derivatized with addition of MTBSTFA
Ž .acetonitrile 1:1 vv to produce a t-BDMS
derivative. Quantification of the natural and 1-
13 C -palmitate fatty acid derivatives was carried
out by GCMS in the electron impact mode. 13CO2
enrichment in breath and heparinized whole blood
samples was determined by gas isotope ratio mass
Ž .spectrometry IRMS on a Europa Scientific
Ž .Crewe, UK 2020 stable isotope analyzer. The
breath samples were loaded directly on the IRMS
via a Europa Scientific ABCA sample purification
system. Blood samples were first acidified with a
saturated citric acid solution to liberate the car-
bon dioxide and the released gas loaded on the
IRMS in the same manner as the breath samples.
2.6. Calculations and statistics
 Ž .The palmitate entry rate R palmitate , thea
 Ž .CO production rate R CO during the bicar-2 a 2
bonate infusion, the palmitate oxidation rate, and
the percent of palmitate uptake oxidized were
Ž .calculated as follows Wolfe, 1992 :
Ž . Ž .R palmitate  E E 1 FŽ .a ip palm palm
Ž . Ž .R CO  E E 1 FŽ .a 2 ib bCO bicarb2
Palmitate oxidation
Ž . E R CO EŽ .pCO a 2 palm2
Palmitate uptake oxidized
Ž . Ž .%  E R CO F 100Ž .ž /pCO a 2 palm2
where E is the isotope enrichment of the 13C-ip
palmitate infusate, E is the plateau enrich-palm
ment of plasma palmitate, F is the infusionpalm
rate of the 13C-palmitate infusate, E is the iso-ib
tope enrichment of the 13C-bicarbonate infusate,
E is the plateau enrichment of plasma orbCO 2
breath CO during the 13C-bicarbonate infusion,2
F is the infusion rate of the 13C-bicarbonatebicarb
infusate, and E is the plateau enrichment ofpCO 2
plasma or breath CO during the 13C-palmitate2
infusion.
Ž .The primary comparisons of interest were i
between fed pigs receiving either the albumin or
the methyl--cyclodextrin complex in order to
evaluate whether the results were similar for the
Ž .two methods and ii between fed and fasted
states in pigs receiving the methyl--cyclodextrin
complex to determine if this method could detect
changes in palmitate oxidation. To compare data
from fed pigs infused with the albumin vs. the
methyl--cyclodextrin complex, ANOVA was
used. For this comparison, the level of signifi-
cance was set at P0.1 and the degrees of
freedom within samples set at 4, to reduce likeli-
hood of a type II error, concluding that there is
no difference between infusion methods, when a
difference does exist. For the fed and fasted states
of pigs receiving the methyl--cyclodextrin com-
Žplex infusion each pig studied under both fed
.and fasted conditions , the average plateau values
were compared using paired t-tests and the level
of significance was set at P0.05. Data in tables
are expressed as meanstandard error of the
Ž .mean S.E.M. .
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3. Results
3.1. Albumin infusion
In an initial infusion with a higher concentra-
Ž .tion of porcine albumin 7% , the pig vomited
within 60 min of initiation of the palmitate
Ž .albumin complex infusion Pig A, see Table 1 ;
rectal temperature was unchanged at T min,30
elevated by 0.5C at T min, 1.0C at T60 90
min, and 1.5C at T min. Frequent tem-120 180
peratures were also taken in a second pig infused
with a 5% albumin complex. It also had elevated
rectal temperature within 60 min of the initiation
of infusion of the complex. Pigs had normal rectal
body temperatures the day following the infusion.
Seven similar pigs received infusions of palmitate
complexed with 5% albumin. One of these pigs
was severely affected by the palmitatealbumin
complex infusion and displayed symptoms of ana-
phylaxis. The pig was distressed, suffered from
extremely labored breathing and exhibited diffuse
erythema or flushing of the skin. The catheters of
this pig also lost patency shortly after the initia-
tion of the albumin infusion, and therefore no
palmitate data were available from this animal.
Albumin without palmitate bound to it was also
infused into one pig and similar adverse respon-
ses were observed.
The palmitate oxidation data obtained from the
pigs infused with palmitatealbumin complexes
are presented in Table 1. Most of these pigs
Žreacted negatively to infusion of albumin i.e.
.vomiting, shaking, fever, andor rapid breathing .
Pigs infused with the palmitatealbumin com-
Žplexes had reduced feed intakes an average re-
.duction of 28% for total daily intake . Most lost
interest in feed within 1 h after initiation of
palmitatealbumin complex infusion and, on av-
erage, consumed less than 20% of the feed of-
fered during this infusion. The variation in feed
consumed, as well as the other symptoms,
probably contributed to the variation in the indi-
vidual values for palmitate oxidation. The ap-
petites of all pigs returned by the day following
the infusion. Four pigs did not vomit and two pigs
 13 infused with the 1- C -palmitatealbumin mix-
ture continued to consume their diet throughout
the infusion period; albeit one at a reduced level.
Summarized oxidation data using the palmitate
albumin complex for three pigs is presented in
Table 2 for a comparison with the pigs receiving
the methyl--cyclodextrin complex.
3.2. Methyl--cyclodextrin infusion
 13 Pigs infused with the 1- C -palmitatemethyl-
-cyclodextrin mixture showed none of the ad-
verse side effects observed with albumin infusion.
Rectal body temperature was unchanged during
palmitatemethyl--cyclodextrin complex infu-
sion. All pigs infused with this complex continued
to consume meals fed hourly during the infusion
and no loss of appetite was observed following
the infusion. The effects of fasting as measured in
 13 pigs infused with the 1- C -palmitatemethyl-
-cyclodextrin mixture are shown in Table 2. In
 13 the animals infused with the 1- C -palmitate
methyl--cyclodextrin complex, fasting increased
Ž .palmitate entry rate 1.8-fold P0.05 and the
Table 2
 Ž .Comparison of albumin and methyl--cyclodextrin as carrier for palmitate for the measurement of palmitate entry rate R palmitatea
1and oxidation
2Albumin Methyl--cyclodextrin
Ž .n3 Ž .n4
Fed Fed Fasted
Mean S.E.M. Mean S.E.M. Mean S.E.M.
1 1 a bA BŽ .R palmitate , mol min kg 4.09 1.03 1.35 0.27 2.46 0.61a
1 1 a aA BŽ .R CO , mol min kg 803 30 1008 87 627 22a 2
a aA BPalmitate oxidation, 0.30 0.13 0.17 0.02 1.44 0.36
1 1
mol min kg
a aA B% Palmitate uptake oxidized 7.3 2.1 13.2 2.0 58.4 1.9
1 ŽValues with different superscripts within the same row are different for fed albumin vs. fed methyl--cyclodextrin, lower case
.letters are used: P0.1; for methyl--cyclodextrin fed vs. fasted, upper case letters are used: P0.05 .
2 Ž .Means of pigs D, E, and G see Table 1 are presented.
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percentage of palmitate uptake oxidized by
Ž .greater than eight-fold P0.001 . Fasting also
Ž .increased palmitate oxidation P0.05 .
3.3. Comparison of palmitate oxidation
A comparison of palmitate oxidation measure-
 13 ments made in pigs infused with the 1- C -
palmitatemethyl--cyclodextrin mixture and pigs
 13 infused with the 1- C -palmitatealbumin mix-
ture is shown in Table 2. Palmitate oxidation
values obtained under fed conditions when 1-
13 C -palmitatemethyl--cyclodextrin complex
was infused were similar to those obtained using
albumin as a carrier; however, the coefficient of
variation was 1.73-fold lower with the methyl--
cyclodextrin mixture. The similarity of plasma
13C-palmitate and breath 13CO enrichments2
Ž .above baseline for representative pigs using
either albumin or methyl--cyclodextrin as carri-
ers are shown in Fig. 1.
4. Discussion
In the present study, we developed and vali-
dated a new technique using methyl--cyclo-
Ždextrin as a carrier rather than fatty acid-free
.albumin for palmitate in vivo infusion studies in
growing pigs. In this study, the fed and fasted
states were used as metabolic tools to elicit known
states of low and high fatty acid oxidation to
determine if the technique could measure these
relatively extreme differences. With fasting, fatty
Žacid oxidation should increase in the pig Cun-
.ningham, 1967 .
Fatty acid-free albumin has been the standard
fatty acid-carrier used in most metabolic studies
Ž .Wolfe, 1992 . However, in this study, the pigs
Žinfused with palmitatealbumin complexes pre-
pared using several sources of porcine and bovine
.fatty acid-free albumin displayed a variety of
adverse reactions. In addition, the experimental
variation in the palmitate oxidation values was
higher in the animals infused with albumin-bound
palmitate. The palmitate oxidation values for the
pigs receiving the palmitatealbumin mixture,
while high for a fed animal, were lower than
those observed in the fasted animals receiving the
palmitatemethyl--cyclodextrin mixture. The
pigs infused with the palmitatealbumin complex
consumed two-thirds of their total diet before the
Ž . Fig. 1. Comparison of a plasma isotopic enrichment of 1-
13  ŽC -palmitate expressed as mol.% excess, MPE, above base-
. Ž . 13 Žline and b breath isotopic enrichment of CO expressed2
.as at.% excess, APE, above baseline from fed pigs during
 13 infusions of either the 1- C -palmitate-methyl--cyclodextrin
Ž .  13 mixture solid circles; n4 or the 1- C -palmitate-albumin
Ž .mixture open circles; n3 . Error bars represent S.E.M.
initiation of the palmitatealbumin complex infu-
sion, and although some regurgitated an unmea-
sured portion of the previously consumed diet,
they were not ‘fasted’. Metabolically, some of the
pigs infused with the palmitatealbumin complex
were probably somewhere between the fed and
Ž .fasted states. The elevated R palmitate valuea
may have been due to the reduced feed intake in
combination with the elimination of digesta from
the stomach via the albumin-induced vomiting.
Ž .The percent of the R palmitate which was oxi-a
dized in the pigs infused with the palmitateal-
bumin mixture was similar to the values observed
in fed pigs infused with the palmitatemethyl--
cyclodextrin mixture.
The palmitate oxidation rates and the percent
of palmitate uptake oxidized in fed pigs obtained
when methyl--cyclodextrin was used as a carrier
for palmitate were not different to when albumin
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Ž .was used as a carrier. The R palmitate valuesa
for fasted pigs were higher than the fed pigs
infused with the palmitatemethyl--cyclodextrin
mixture, demonstrating that the methyl--cyclo-
dextrin method can detect expected differences in
fatty acid oxidation. This was further supported
by comparison with fasted and fed values in the
literature. In pigs where methyl--cyclodextrin
was used as a carrier, the palmitate oxidation
increased 512-fold when the pigs were fasted as
compared to oxidation rates observed in the fed-
state. This was a similar percentage increase to
Ž .that which was observed by Cunningham 1967 in
Ž .fed and fasted pigs 65 kg using radioisotopic
techniques with infusion of 14 C-palmitate bound
to ox albumin.
We did not determine the associationdisas-
sociation properties of palmitatemethyl--
cyclodextrin. However, in in vitro studies, -
cyclodextrin behaved similarly to defatted serum
Ž .albumin Ramadoss et al., 1976 , and methylated
-cyclodextrin did not inhibit palmitate oxidation
or impede palmitate bioavailability in vitro for
Ž .Mycobacterium leprae Ishaque, 1992 . Our data
suggested that this is true for in vivo studies as
well.
ŽOther studies using the pig model Cun-
ningham, 1967; Boyd et al., 1982; Dunshea et al.,
.1992 have utilized bovine or porcine albumin or
autologous serum as a carrier for 14 C-fatty acids
without negative side effects. However, relatively
Žsmall amounts of radioactive tracers as used in
14 .those C studies need to be infused to measure
metabolite fluxes as compared to stable isotopic
tracers, and therefore studies using radioactive
fatty acid tracers require less total albumin to be
infused. For example in the present study, we
infused albumin at 39 mg kg1 h1, and in a
study using pigs of a similar weight, approximately
6 mg kg1 h1 of albumin was infused when a
Ž .radioisotope was used Dunshea et al., 1992 , a
difference greater than six-fold.
We did not determine the exact cause of the
adverse reactions to albumin infusion, but the
symptoms observed were consistent with anaphy-
laxis. Previous experience has shown that pigs are
very sensitive to pyrogens and endotoxins in intra-
venous solutions and feed contaminants that do
not appear to adversely affect some other species
Ž .Wray-Cahen, unpublished data . Use of essen-
tially -globulin-free and low endotoxin prepara-
tions of bovine albumin reduced, but did not
eliminate, the adverse reactions, nor did their use
prevent the suppression of food intake. We were
unable to obtain the fatty acid-free albumin rou-
tinely used in human studies to provide a direct
comparison, but it is possible that pigs would
experience heterologous anaphylaxis with al-
bumin of human origin as well, irrespective of the
purity. A porcine albumin comparable to that
used in human studies was not commercially
available. While severe adverse reactions to hu-
man serum albumin infusion in man are relatively
rare, intolerance to infusion of human albumin,
including pyrogenic and anaphylactic reactions
ŽRing et al., 1979; Stafford et al., 1988; Leach,
.1991; Pool and McLeod, 1995 , and possibly an
Žincreased risk of mortality Cochrane Injuries
.Group, 1998 , have been reported.
We did not observe any adverse side effects
while using methyl--cyclodextrin as a non-
blood-derived alternative to serum albumin as a
 13 carrier for 1- C -palmitate. This could be due, in
part, to the lower volume of methyl--cyclo-
dextrin compared to albumin infused. However,
Ž .this was not likely, because: i we infused one
Ž .animal data not shown at a higher infusion rate
Ž .using 10% methyl--cyclodextrin and observed
Ž .no adverse reactions; and ii we have observed
no adverse reactions in pigs receiving much higher
Žinfusion rates of other compounds e.g. infusion
of glucose during hyperinsulinemiceuglycemic
.clamps . Use of -cyclodextrins may allow for a
higher infusion rate of a fatty acid tracer than
possible when albumin is used as a carrier. Cy-
clodextrins have some additional potential advan-
tages over albumin. For example, methyl--
cyclodextrin is more readily available than infu-
sion-quality albumin and is more cost-effective.
Cyclodextrins have potentially much less batch-
to-batch variation and are free of contaminating
biological substances, such as residual fatty acids
and immunoglobulins. Refrigeration of the palmi-
tatealbumin mixture can also lead to the forma-
tion of compounds that are pyrogenic in nature
Ž .for humans Wolfe 1992 ; this did not appear to
be a problem with methyl--cyclodextrin.
Interest in cyclodextrins has been increasing,
both for their use in drug delivery and formula-
Žtion Rajewski and Stella, 1997; Stella and Rajew-
.ski, 1997; Thompson, 1997 and for their potential
Žas a lipid carrier in parenteral nutrition Brewster
et al., 1989; Ohtani et al., 1989; Irie et al., 1992;
.Thompson, 1997 . Although infusion of unsubsti-
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tuted -cyclodextrin is unsafe due to its nephro-
Ž .toxicity Stella and Rajewski 1997 , modified cy-
clodextrins vary with regard to this trait of their
Ž .parent compound. Irie et al. 1992 infused hy-
droxypropyl -cyclodextrin parenterally into hu-
mans without irritation. They also infused hydrox-
ypropyl -cyclodextrin parenterally into rabbits
with no observed morphological changes in most
Ž .organs including liver . However, very high infu-
sion rates of hydroxypropyl--cyclodextrin did re-
sult in some morphological changes in the kid-
neys, similar to those observed with large i.v.
doses of glucose, sucrose, mannitol, or dextran
Ž .Irie et al., 1992 . This may be associated with its
route of clearance. Clearance of i.v.-administered
hydroxypropyl--cyclodextrin, dimethyl--cyclo-
dextrin, and -cyclodextrin appears to be primar-
ily via glomerular filtration, with approximately
90% of infused cyclodextrin appearing in the urine
Žwithin less than 24 h Frijlink et al., 1990; Pitha et
al., 1994; Kubota et al., 1996; McCormack and
.Gregoriadis, 1996; Thompson, 1997 . Grosse et al.
Ž .1999 reported the pharmacokinetics of methyl-
-cyclodextrin in rabbits. They reported a dis-
tribution time of approximately 30 min and a
half-life of 7 h. Appearance in urine was not
determined in that study, but methyl--cyclo-
dextrin levels in the kidney were high within 4 h.
It seems highly probable that methyl--cyclo-
dextrin administered i.v. is also cleared by the
kidneys.
The ability to tolerate oral or i.v. dosing of
cyclodextrins appears to vary with species. Cats
have demonstrated adverse reactions to high infu-
Žsion rates of methyl--cyclodextrin personal
communication, Dr S.A. Center, Cornell Univer-
.sity and dogs appear to tolerate long-term di-
etary inclusion of -cyclodextrin better than rats
Ž .Thompson, 1997 . Methylated -cyclodextrins
Žwith a high degree of substitution di-methyl and
.tri-methyl -cyclodextrin have been found to have
toxic effects when given parenterally, but both
rabbits and mice have been infused with high
doses of methyl--cyclodextrin without exhibiting
Ž .any toxic effects Grosse et al., 1999 . The safety
of i.v. administration of methyl--cyclodextrin has
not been fully explored.
Although it was not measured in this study,
there is the potential for methyl--cyclodextrin to
bind or complex with other lipophilic compounds
in the circulation. There is evidence that cy-
clodextrins have the capacity to bind to and re-
move cholesterol, vitamin A, bile salts, triglyc-
erides and potentially other lipophilic compounds
Žfrom the blood Ferezou et al., 1997; Rajewski
.and Stella, 1997; Thompson, 1997 . In pigs, 5 and
10% -cyclodextrin diets reduced levels of choles-
terol in blood and liver when a high cholesterol
Ž .diet was fed Ferezou et al., 1997 . Addition of
-cyclodextrin to diets also reduced cholesterol
Ž .levels in rats and dogs Rajewski and Stella, 1997 .
It is possible that infused cyclodextrins may bind
to other lipophilic compounds as well. The physi-
ological result of -cyclodextrin binding to
lipophilic compounds may not be predictable 
in vitro studies suggested that -cyclodextrins may
make some compounds more available to cells
Ž .Christian et al., 1999 and the cholesterol-lower-
ing effect of oral -cyclodextrin has not been
Ž .consistent in different species Thompson, 1997 .
In conclusion, we have demonstrated the feasi-
bility of using methyl--cyclodextrin as a substi-
tute for albumin as a carrier for 13C-palmitate in
in vivo infusion studies to determine the rate of
turnover and oxidation of plasma palmitate in
pigs. The 13C-palmitatemethyl--cyclodextrin
complex was stable at room temperature and the
palmitate tracer complexed with methyl--cyclo-
dextrin has been demonstrated to be available in
vivo. Methyl--cyclodextrin did not have the neg-
ative side effects that we have observed with
albumin infusion into pigs. Therefore, it may be a
promising non-blood-derived alternative to serum
albumin for use as a fatty acid-tracer carrier in
fatty acid oxidation studies in growing pigs.
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